Cargando…

Development of a self-administered early inflammatory arthritis detection tool

BACKGROUND: Barriers to care limit the potential benefits of pharmacological intervention for inflammatory arthritis. A self-administered questionnaire for early inflammatory arthritis (EIA) detection may complement contemporary triage interventions to further reduce delays to rheumatologic care. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Mary J, Tavares, Ruben, Guillemin, Francis, Bykerk, Vivian P, Tugwell, Peter, Wells, George A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851668/
https://www.ncbi.nlm.nih.gov/pubmed/20236522
http://dx.doi.org/10.1186/1471-2474-11-50
_version_ 1782179891547996160
author Bell, Mary J
Tavares, Ruben
Guillemin, Francis
Bykerk, Vivian P
Tugwell, Peter
Wells, George A
author_facet Bell, Mary J
Tavares, Ruben
Guillemin, Francis
Bykerk, Vivian P
Tugwell, Peter
Wells, George A
author_sort Bell, Mary J
collection PubMed
description BACKGROUND: Barriers to care limit the potential benefits of pharmacological intervention for inflammatory arthritis. A self-administered questionnaire for early inflammatory arthritis (EIA) detection may complement contemporary triage interventions to further reduce delays to rheumatologic care. The objective of this study was to develop a self-administered EIA detection tool for implementation in pre-primary care settings. METHODS: A core set of dimensions and constructs for EIA detection were systematically derived from the literature and augmented by investigative team arbitration. Identified constructs were formulated into lay language questions suitable for self-administration. A three-round Delphi consensus panel of EIA experts and stakeholders evaluated the relevance of each question to EIA detection and suggested additional items. Questions accepted by less than 70% of respondents in rounds one or two were eliminated. In round three, questions accepted by at least 80% of the panel were selected for the tool. RESULTS: Of 584 citations identified, data were extracted from 47 eligible articles. Upon arbitration of the literature synthesis, 30 constructs encompassing 13 dimensions were formulated into lay language questions and posed to the Delphi panel. A total of 181 EIA experts and stakeholders participated on the Delphi panel: round one, 60; round two, 59; and, round three, 169; 48 participated in all three rounds. The panel evaluated the 30 questions derived from the literature synthesis, suggested five additional items, and eliminated a total of 24. The eleven-question instrument developed captured dimensions of articular pain, swelling, and stiffness, distribution of joint involvement, function, and diagnostic and family history. CONCLUSIONS: An eleven-question, EIA detection tool suitable for self-administration was developed to screen subjects with six to 52 weeks of musculoskeletal complaints. Psychometric and performance property testing of the tool is ongoing.
format Text
id pubmed-2851668
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28516682010-04-09 Development of a self-administered early inflammatory arthritis detection tool Bell, Mary J Tavares, Ruben Guillemin, Francis Bykerk, Vivian P Tugwell, Peter Wells, George A BMC Musculoskelet Disord Research article BACKGROUND: Barriers to care limit the potential benefits of pharmacological intervention for inflammatory arthritis. A self-administered questionnaire for early inflammatory arthritis (EIA) detection may complement contemporary triage interventions to further reduce delays to rheumatologic care. The objective of this study was to develop a self-administered EIA detection tool for implementation in pre-primary care settings. METHODS: A core set of dimensions and constructs for EIA detection were systematically derived from the literature and augmented by investigative team arbitration. Identified constructs were formulated into lay language questions suitable for self-administration. A three-round Delphi consensus panel of EIA experts and stakeholders evaluated the relevance of each question to EIA detection and suggested additional items. Questions accepted by less than 70% of respondents in rounds one or two were eliminated. In round three, questions accepted by at least 80% of the panel were selected for the tool. RESULTS: Of 584 citations identified, data were extracted from 47 eligible articles. Upon arbitration of the literature synthesis, 30 constructs encompassing 13 dimensions were formulated into lay language questions and posed to the Delphi panel. A total of 181 EIA experts and stakeholders participated on the Delphi panel: round one, 60; round two, 59; and, round three, 169; 48 participated in all three rounds. The panel evaluated the 30 questions derived from the literature synthesis, suggested five additional items, and eliminated a total of 24. The eleven-question instrument developed captured dimensions of articular pain, swelling, and stiffness, distribution of joint involvement, function, and diagnostic and family history. CONCLUSIONS: An eleven-question, EIA detection tool suitable for self-administration was developed to screen subjects with six to 52 weeks of musculoskeletal complaints. Psychometric and performance property testing of the tool is ongoing. BioMed Central 2010-03-17 /pmc/articles/PMC2851668/ /pubmed/20236522 http://dx.doi.org/10.1186/1471-2474-11-50 Text en Copyright ©2010 Bell et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Bell, Mary J
Tavares, Ruben
Guillemin, Francis
Bykerk, Vivian P
Tugwell, Peter
Wells, George A
Development of a self-administered early inflammatory arthritis detection tool
title Development of a self-administered early inflammatory arthritis detection tool
title_full Development of a self-administered early inflammatory arthritis detection tool
title_fullStr Development of a self-administered early inflammatory arthritis detection tool
title_full_unstemmed Development of a self-administered early inflammatory arthritis detection tool
title_short Development of a self-administered early inflammatory arthritis detection tool
title_sort development of a self-administered early inflammatory arthritis detection tool
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851668/
https://www.ncbi.nlm.nih.gov/pubmed/20236522
http://dx.doi.org/10.1186/1471-2474-11-50
work_keys_str_mv AT bellmaryj developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool
AT tavaresruben developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool
AT guilleminfrancis developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool
AT bykerkvivianp developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool
AT tugwellpeter developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool
AT wellsgeorgea developmentofaselfadministeredearlyinflammatoryarthritisdetectiontool